What is it about?
Imipenem-cilastatin, a carbapenem antibiotic, is commonly used for severe bacterial infections. While generally well-tolerated, it can rarely cause central nervous system toxicity, including seizures. We have, herein, reported a case of imipenem-cilastatin-induced seizure in a 20-year-old patient.
Featured Image
Why is it important?
Our case has highlighted the importance of promptly recognizing imipenem-cilastatin- induced epileptic seizures in order to treat them more effectively and thus optimize the patient's care. Therefore, we emphasize that clinicians be vigilant about the side effects of its use, particularly in patients with neurological susceptibilities. We also advocate a personalized choice of antibiotics, taking into account both antimicrobial efficacy and potential adverse effects, for better outcomes with fewer risks.
Read the Original
This page is a summary of: Imipenem-Cilastatin-Induced Seizures: A Case Report, Current Drug Safety, August 2025, Bentham Science Publishers,
DOI: 10.2174/0115748863324094240919114700.
You can read the full text:
Contributors
The following have contributed to this page







